Ikarisoside F

CAS# 113558-14-8

Ikarisoside F

2D Structure

Catalog No. BCN2284----Order now to get a substantial discount!

Product Name & Size Price Stock
Ikarisoside F: 5mg Please Inquire In Stock
Ikarisoside F: 10mg Please Inquire In Stock
Ikarisoside F: 20mg Please Inquire Please Inquire
Ikarisoside F: 50mg Please Inquire Please Inquire
Ikarisoside F: 100mg Please Inquire Please Inquire
Ikarisoside F: 200mg Please Inquire Please Inquire
Ikarisoside F: 500mg Please Inquire Please Inquire
Ikarisoside F: 1000mg Please Inquire Please Inquire

Quality Control of Ikarisoside F

3D structure

Package In Stock

Ikarisoside F

Number of papers citing our products

Chemical Properties of Ikarisoside F

Cas No. 113558-14-8 SDF Download SDF
PubChem ID 5318413 Appearance Yellow powder
Formula C31H36O14 M.Wt 632.62
Type of Compound Flavonoids Storage Desiccate at -20°C
Synonyms Ikarisoside-F; Icarisoside-F
Solubility Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc.
Chemical Name 3-[(2S,3R,4S,5R)-4,5-dihydroxy-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-5,7-dihydroxy-2-(4-hydroxyphenyl)-8-(3-methylbut-2-enyl)chromen-4-one
SMILES CC1C(C(C(C(O1)OC2C(C(COC2OC3=C(OC4=C(C3=O)C(=CC(=C4CC=C(C)C)O)O)C5=CC=C(C=C5)O)O)O)O)O)O
Standard InChIKey JFEVWNOGUFYCOV-NPFMWIEOSA-N
Standard InChI InChI=1S/C31H36O14/c1-12(2)4-9-16-17(33)10-18(34)20-23(38)28(26(43-27(16)20)14-5-7-15(32)8-6-14)44-31-29(22(37)19(35)11-41-31)45-30-25(40)24(39)21(36)13(3)42-30/h4-8,10,13,19,21-22,24-25,29-37,39-40H,9,11H2,1-3H3/t13-,19+,21-,22-,24+,25+,29+,30-,31-/m0/s1
General tips For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months.
We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months.
Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it.
About Packaging 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial.
2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial.
3. Try to avoid loss or contamination during the experiment.
Shipping Condition Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request.

Source of Ikarisoside F

The roots of Epimedium brevicornu Maxim

Biological Activity of Ikarisoside F

Description1. Ikarisoside F and epimedin A can bind to AdoHcy hydrolase, inhibit the activity of AdoHcy hydrolase, thus regulating the cellular biomethylation as well as reducing cellular Hcy level.

Ikarisoside F Dilution Calculator

Concentration (start)
x
Volume (start)
=
Concentration (final)
x
Volume (final)
 
 
 
C1
V1
C2
V2

calculate

Ikarisoside F Molarity Calculator

Mass
=
Concentration
x
Volume
x
MW*
 
 
 
g/mol

calculate

Preparing Stock Solutions of Ikarisoside F

1 mg 5 mg 10 mg 20 mg 25 mg
1 mM 1.5807 mL 7.9036 mL 15.8073 mL 31.6146 mL 39.5182 mL
5 mM 0.3161 mL 1.5807 mL 3.1615 mL 6.3229 mL 7.9036 mL
10 mM 0.1581 mL 0.7904 mL 1.5807 mL 3.1615 mL 3.9518 mL
50 mM 0.0316 mL 0.1581 mL 0.3161 mL 0.6323 mL 0.7904 mL
100 mM 0.0158 mL 0.079 mL 0.1581 mL 0.3161 mL 0.3952 mL
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations.

Organizitions Citing Our Products recently

 
 
 

Calcutta University

University of Minnesota

University of Maryland School of Medicine

University of Illinois at Chicago

The Ohio State University

University of Zurich

Harvard University

Colorado State University

Auburn University

Yale University

Worcester Polytechnic Institute

Washington State University

Stanford University

University of Leipzig

Universidade da Beira Interior

The Institute of Cancer Research

Heidelberg University

University of Amsterdam

University of Auckland
TsingHua University
TsingHua University
The University of Michigan
The University of Michigan
Miami University
Miami University
DRURY University
DRURY University
Jilin University
Jilin University
Fudan University
Fudan University
Wuhan University
Wuhan University
Sun Yat-sen University
Sun Yat-sen University
Universite de Paris
Universite de Paris
Deemed University
Deemed University
Auckland University
Auckland University
The University of Tokyo
The University of Tokyo
Korea University
Korea University

Background on Ikarisoside F

Ikarisoside F is a flavonol glycoside from Vancouveria hexandra; could bind to AdoHcy hydrolase.

References:
[1]. Mizuno M, et al. Two flavonol glycosides from Vancouveria hexandra. Phytochemistry. 1992 Jan;31(1):297-9. [2]. Zhang X, et al. Inhibitory effect of Epimedium extract on S-adenosyl-L-homocysteine hydrolase and biomethylation. Life Sci. 2005 Nov 26;78(2):180-6.

Featured Products
New Products
 

References on Ikarisoside F

Two flavonol glycosides from Vancouveria hexandra.[Pubmed:1367883]

Phytochemistry. 1992 Jan;31(1):297-9.

In addition to two known glycosides, Ikarisoside F and epimedin A, two new glycosides of a flavonol with a gamma, gamma-dimethylallyl group were isolated from the underground and the aerial parts of Vancouveria hexandra. The structures were determined to be des-O-methylanhydroicaritin 3,7-diglucoside and anhydroicaritin 3-glucosyl (1----3)rhamnoside-7-glucoside by means of spectral analysis.

Inhibitory effect of Epimedium extract on S-adenosyl-L-homocysteine hydrolase and biomethylation.[Pubmed:16125732]

Life Sci. 2005 Nov 26;78(2):180-6.

In the present paper, the inhibitory effect of Epimedium extract on the activity of S-adenosyl-L-homocysteine (AdoHcy) Hydrolase was studied. The results showed that Epimedium extract inhibited the activity of recombinant human AdoHcy hydrolase in a dose-dependent manner. This inhibitory effect was also observed in hepatic cell line 7701 and hepatoma HepG2, however, the effect in 7701 cells was more potent than in HepG2 cells. The extract could significantly reduce AdoMet/AdoHcy ratio in 7701 cells in a dose-dependent manner, suggesting reduced biomethylation level in 7701 cells. In contrast, it resulted in elevated AdoMet/AdoHcy ratio in the HepG2 cells. The result of MALDI-MS assay indicated that epimedin A and Ikarisoside F from the extract could bind to AdoHcy hydrolase. The present data suggested that Epimedium extract could inhibit the activity of AdoHcy hydrolase, thus regulating the cellular biomethylation as well as reducing cellular Hcy level. These results will provide new clues to the mechanisms of Epimedium in curing of cardiovascular disease and regulating tumor cell growth.

Description

Ikarisoside F is a flavonol glycoside from Vancouveria hexandra; could bind to AdoHcy hydrolase.

Keywords:

Ikarisoside F,113558-14-8,Ikarisoside-F; Icarisoside-F,Natural Products, buy Ikarisoside F , Ikarisoside F supplier , purchase Ikarisoside F , Ikarisoside F cost , Ikarisoside F manufacturer , order Ikarisoside F , high purity Ikarisoside F

Online Inquiry for:

      Fill out the information below

      • Size:Qty: - +

      * Required Fields

                                      Result: